67. 多発性嚢胞腎 Polycystic kidney disease Clinical trials / Disease details

臨床試験数 : 221 / 薬物数 : 212 - (DrugBank : 55) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 151

21 trials found

diseases per page:

Showing 1 to 10 of 21 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-004400-34-NL (EUCTR)	12/05/2021	04/02/2021	Long-term treatment of autosomal dominant polycystic kidney disease (ADPKD) with venglustat	Multicenter, open-label, extension study to characterize the long-term efficacy and safety of early ...	Congenital cystic kidney disease MedDRA version: 20.0;Level: PT;Classification code 10010428;Term: C ...	Product Name: Venglustat Product Code: SAR402671, GZ402671 or GZ/SAR402671 INN or Proposed INN: venglu ...	Sanofi-Aventis Recherche & Développement	NULL	Not Recruiting			Female: yes Male: yes	640	Phase 3	Portugal;Taiwan;Spain;Turkey;Israel;United Kingdom;Italy;France;Czech Republic;Canada;Argentina;Pola ...
2	EUCTR2020-004400-34-BE (EUCTR)	11/05/2021	18/02/2021	Long-term treatment of autosomal dominant polycystic kidney disease (ADPKD) with venglustat	Multicenter, open-label, extension study to characterize the long-term efficacy and safety of early ...	Congenital cystic kidney disease MedDRA version: 20.0;Level: PT;Classification code 10010428;Term: C ...	Product Name: Venglustat Product Code: SAR402671, GZ402671 or GZ/SAR402671 INN or Proposed INN: venglu ...	Sanofi-Aventis Recherche & Développement	NULL	Not Recruiting			Female: yes Male: yes	640	Phase 3	Portugal;Czechia;Taiwan;Spain;Turkey;Israel;United Kingdom;Italy;France;Canada;Argentina;Poland;Belg ...
3	EUCTR2020-004400-34-PT (EUCTR)	30/04/2021	05/03/2021	Long-term treatment of autosomal dominant polycystic kidney disease (ADPKD) with venglustat	Multicenter, open-label, extension study to characterize the long-term efficacy and safety of early ...	Congenital cystic kidney disease MedDRA version: 20.0;Level: PT;Classification code 10010428;Term: C ...	Product Name: Venglustat Product Code: SAR402671, GZ402671 or GZ/SAR402671 INN or Proposed INN: venglu ...	Sanofi-Aventis Recherche & Développement	NULL	Not Recruiting			Female: yes Male: yes	640	Phase 3	Portugal;Czechia;Taiwan;Spain;Turkey;Israel;United Kingdom;Italy;France;Canada;Argentina;Poland;Belg ...
4	EUCTR2020-004400-34-IT (EUCTR)	14/04/2021	08/06/2021	Long-term treatment of autosomal dominant polycystic kidney disease (ADPKD) with venglustat	Multicenter, open-label, extension study to characterize the long-term efficacy and safety of early ...	Congenital cystic kidney disease MedDRA version: 20.0;Level: PT;Classification code 10010428;Term: C ...	Product Name: Venglustat Product Code: [SAR402671, GZ402671 o GZ/SAR402671] INN or Proposed INN: vengl ...	SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT	NULL	Not Recruiting			Female: yes Male: yes	640	Phase 3	Portugal;Czechia;Taiwan;Spain;Turkey;Israel;United Kingdom;Italy;France;Canada;Argentina;Poland;Belg ...
5	EUCTR2020-004400-34-DE (EUCTR)	23/03/2021	25/02/2021	Long-term treatment of autosomal dominant polycystic kidney disease (ADPKD) with venglustat	Multicenter, open-label, extension study to characterize the long-term efficacy and safety of early ...	Congenital cystic kidney disease MedDRA version: 20.0;Level: PT;Classification code 10010428;Term: C ...	Product Name: Venglustat Product Code: SAR402671, GZ402671 or GZ/SAR402671 INN or Proposed INN: venglu ...	Sanofi-Aventis Recherche & Développement	NULL	Not Recruiting			Female: yes Male: yes	640	Phase 3	Portugal;Czechia;Taiwan;Spain;Turkey;Israel;United Kingdom;Italy;France;Canada;Argentina;Poland;Belg ...
6	NCT04705051 (ClinicalTrials.gov)	February 9, 2021	8/1/2021	Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat	Multicenter, Open-label, Extension Study to Characterize the Long-term Efficacy and Safety of Early ...	Congenital Cystic Kidney Disease	Drug: Venglustat GZ402671	Sanofi	NULL	Terminated	18 Years	N/A	All	24	Phase 3	United States;Australia;Belgium;Germany;Japan;Korea, Republic of;Netherlands;Spain;France;Romania
7	JPRN-jRCT2031200348	09/02/2021	05/02/2021	Long-term treatment of autosomal dominant polycystic kidney disease (ADPKD) with venglustat	Multicenter, open-label, extension study to characterize the long-term efficacy and safety of early ...	Congenital cystic kidney disease	Drug: Venglustat (GZ402671) Pharmaceutical form: capsule, Route of administration: oral	Tanaka Tomoyuki	NULL	Suspended	>= 18age old	Not applicable	Both	640	Phase 3	United States;Japan
8	EUCTR2017-004084-12-AT (EUCTR)	11/04/2019	14/01/2019	A Medical Research Study Designed to Determine if Venglustatcan be a Future Treatment for ADPKD Pati ...	Multicenter, Randomized, Double-blind, Placebo-controlled Two Stage Study to Characterize the Effica ...	Congenital, hereditary and neonatal diseases MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Product Name: Venglustat Product Code: SAR402671, GZ402671 or GZ/SAR402671 INN or Proposed INN: Venglu ...	Genzyme Corporation	NULL	Not Recruiting			Female: yes Male: yes	982	Phase 2	United States;Portugal;Czechia;Taiwan;Spain;Austria;United Kingdom;Switzerland;Italy;France;Czech Re ...
9	EUCTR2017-004084-12-RO (EUCTR)	25/03/2019	23/05/2022	Study of Efficacy, Safety, Tolerability and Pharmacokinetics of GZ/SAR402671 in Patients at risk of ...	Multicenter, Randomized, Double-blind, Placebo-controlled Two Stage Study to Characterize the Effica ...	Congenital, hereditary and neonatal diseases MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Product Name: Venglustat Product Code: SAR402671, GZ402671 or GZ/SAR402671 INN or Proposed INN: Venglu ...	Genzyme Corporation	NULL	Not Recruiting			Female: yes Male: yes	836	Phase 2	Portugal;United States;Czechia;Taiwan;Spain;Austria;United Kingdom;Italy;Switzerland;France;Czech Re ...
10	EUCTR2017-004084-12-NL (EUCTR)	13/02/2019	06/06/2018	A Medical Research Study Designed to Determine if Venglustatcan be a Future Treatment for ADPKD Pati ...	Multicenter, Randomized, Double-blind, Placebo-controlled Two Stage Study to Characterize the Effica ...	Congenital, hereditary and neonatal diseases MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Product Name: Venglustat Product Code: SAR402671, GZ402671 or GZ/SAR402671 INN or Proposed INN: Venglu ...	Genzyme Corporation	NULL	Not Recruiting			Female: yes Male: yes	982	Phase 2	United States;Portugal;Czechia;Taiwan;Spain;Turkey;Austria;Israel;United Kingdom;Italy;France;Czech ...

First Previous1 2 3Next Last